HEREDITARY BREAST CANCER

HEREDITARY BREAST CANCER

Hereditary breast cancer occurs in 5–20 % of cases and it is associated with inherited mutations in particular genes, such as BRCA1 и BRCA2 in most cases. The CHEK2, PTEN, TP53, ATM, RAD51, BLM, PALB2, Nbs genes are associated with low and median risks ofdeveloping breast cancer. Molecular genetic s...

Full description

Bibliographic Details
Main Authors:	E. M. Bit-Sava, N. B. Belogurova
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2016-02-01
Series:	Сибирский онкологический журнал
Subjects:	brca-ассоциированный триждынегативный рак молочной железы ингибиторы parp
Online Access:	https://www.siboncoj.ru/jour/article/view/85

Similar Items

HEREDITARY MULTIPLE PRIMARY BREAST AND OVARIAN CANCER (CASE REPORT)
by: Е. V. Panferova, et al.
Published: (2016-02-01)

Hereditary breast cancer and ovarian cancer: clinical course and treatment
by: V. V. Semiglazov, et al.
Published: (2021-03-01)

Genotype-phenotype correlations in patients with breast cancer and BRCA1 mutations (4153delA, 185delAG, 5382insC)
by: Ye. M. Bit-Sava, et al.
Published: (2014-07-01)

The overview of modern approaches in treatment of triple negative breast cancer
by: A. A. Kharitonova, et al.
Published: (2020-03-01)

HEREDITARY CHARACTERISTICS BRCA1 5382INSC/СHEK2/BLM-ASSOCIATED BREAST CANCER
by: Е. М. Bit-Sava
Published: (2016-02-01)

Ethnic aspects of hereditary breast cancer
by: P. A. Gervas, et al.
Published: (2019-04-01)

PARP1 inhibitors in breast cancer therapy. Mechanism of action and clinical use
by: D. S. Dolgasheva, et al.
Published: (2020-06-01)

Adjuvant hormone therapy in postmenopausal patients with locally advanced breast cancer: hope and reality
by: V. I. Borisov
Published: (2014-07-01)

Evolution of systemic treatment for hormone-sensitive breast cancer: from sequential use of single agents to the upfront administration of drug combinations
by: E. N. Imyanitov
Published: (2016-09-01)

Antiestrogennaya terapiya pri rake molochnoy zhelezy. Naskol'ko bezopasny ingibitory aromatazy?
by: V V Ptushkin
Published: (2007-03-01)

Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors
by: E. V. Artamonova, et al.
Published: (2019-09-01)

Occurrence of BRCA1 and BRCA2 mutation in pancreatic cancer patients
by: A. A. Kashintsev, et al.
Published: (2016-02-01)

CLINICAL AND MORPHOLOGICAL FEATURES OF HEREDITARY OVARIAN CANCER
by: K. B. Kotiv, et al.
Published: (2017-12-01)

Denosumab (AMG-162) v profilaktike osteoporoza, vyzvannogo priemom ingibitorov aromatazy u bol'nykh rakom molochnoy zhelezy v ad\"yuvantnoy terapii i u bol'nykh rakom predstatel'noy zhelezy pri polnoy androgennoy blokade
by: M R Lichinitser, et al.
Published: (2009-12-01)

Evaluation of the scientific results of the study entitled “Opportunities for surgical treatment of patients with stage IV breast cancer” performed by Russian Society of Oncomammologists (RSOM)
by: A. A. Bozhok, et al.
Published: (2017-02-01)

Significance and possible causes of hormone receptor expression loss in metastatic breast cancer. Phenotypic evolution of luminal <i>BRCA1</i>-associated breast cancer to triple negative subtype in lung metastasis and PARP inhibition strategy in early-line therapy
by: A. I. Stukan, et al.
Published: (2022-12-01)

Tactics of radiographic diagnostics of breast cancer in women with inherited predisposition
by: M. S. Karpova, et al.
Published: (2015-01-01)

Breast magnetic resonance imaging significance for breast cancer diagnostic in women with genetic predisposition and a strong family history
by: M. S. Karpova, et al.
Published: (2014-07-01)

REPARATION SYSTEM GENES: POPULATION DIFFERENCES IN HEREDITARY OVARIAN AND BREAST CANCER DETERMINED BY NEXT-GENERATION SEQUENCING
by: O. I. Brovkina, et al.
Published: (2017-06-01)

Role of BRCA 1 и BRCA 2 gene mutations in the occurrence of male breast cancer
by: A. V. Bykova, et al.
Published: (2014-07-01)

Breast cancer risk factors assessment and BRCA-associated breast cancer evaluation in mammographic screening in India
by: S. K. Ternovoy, et al.
Published: (2014-07-01)

BRCA1, BRCA2 mutations — future of predictive oncology: a review of literature
by: V. N. Dmitriev, et al.
Published: (2014-07-01)

X-ray and ultrasound semiotics of mucinous carcinoma of the breast
by: K. A. Lesko, et al.
Published: (2014-07-01)

Biological rationale for patient-specific treatment of breast cancer. Analysis of new data for breast cancer
by: R. M. Paltuev
Published: (2020-03-01)

Problems in the treatment of dyshormonal breast hyperplasia: current aspects
by: E. A. Sukhareva, et al.
Published: (2014-08-01)

SCREENING FOR EARLY DETECTION OF BREAST CANCER
by: E. A. Rasskazova, et al.
Published: (2015-01-01)

Clinical case of torpid course of metastatic triple negative breast cancer
by: E. P. Kulikov, et al.
Published: (2022-03-01)

DETECTION OF MUTATIONS RELATED TO HEREDITARY CANCER IN RELATIVES OF BREAST CANCER PATIENTS
by: G. A. Paul, et al.
Published: (2017-09-01)

Results of a preliminary analysis of the pattern of hereditary breast cancer in the women of a Kyrgyz population
by: K. B. Makieva, et al.
Published: (2014-07-01)

CDK4/6 inhibitors in the treatment of metastatic breast cancer. Choosing optimal therapy for estrogen-receptor-positive HER2-negative metastatic breast cancer: analysis of doctors’ preferences (“Prometheus”) in Russia – first results of the survey
by: E. V. Artamonova, et al.
Published: (2021-01-01)

Inhibition of glucocorticoid-induced REDD1 expression by rapamycin in breast cancer cells
by: D. D. Grigorieva, et al.
Published: (2022-03-01)

Neoadjuvant treatment for breast cancer
by: V. F. Semiglazov, et al.
Published: (2014-07-01)

Femara (letrozol) v ad\"yuvantnoy terapii raka molochnoy zhelezy
by: M B Stenina
Published: (2007-09-01)

Tumor immune microenvironment and apoptotic markers in breast cancer patients carrying <I>BRCA1</I> gene mutations
by: A. I. Stukan, et al.
Published: (2022-09-01)

The role of digital mammography, scintimammography with <sup>99m </sup>Tc-methoxyisobutylisonitrile (MIBI) and ultrasound in the diagnosis of multicentric breast cancer
by: A. V. Chernaya, et al.
Published: (2020-03-01)

Ovarian cancer: new accents treatment of patients with platinum-sensitive relapses
by: A. G. Kedrova, et al.
Published: (2016-11-01)

DIAGNOSIS OF MUCINOUS BREAST CANCER
by: E. К. Saribekyan, et al.
Published: (2016-02-01)

Occult breast cancer. Literature review and case series
by: О. S. Khodorovich, et al.
Published: (2021-03-01)

Anamnesis peculiarities of BRCA1-associated breast cancer in young women
by: D. E. Avtomonov, et al.
Published: (2014-07-01)

Subtypes of breast cancer
by: D. D. Pak, et al.
Published: (2014-07-01)